Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 36 of the 36 references it cites were found in a registry or an index.

Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation

Rickels, Karl · 1990 · Archives of General Psychiatry

Abstract

We compared the effect of abrupt discontinuation of therapeutic doses of short half-life and long half-life benzodiazepines in 57 benzodiazepine-dependent patients (daily use, greater than 1 year). Despite the use of a mean daily dose of 14.1 mg of diazepam equivalents, there were notable residual symptoms of anxiety and depression present at intake (Hamilton Rating Scale for Anxiety score, 17.0; Hamilton Rating Scale for Depression score, 14.0). Benzodiazepine intake was stabilized for 3 weeks before double-blind assignment to placebo (n = 47), or continued benzodiazepine use (n = 10). Clinical assessments were performed daily, including benzodiazepine plasma levels. Depending on the outcome criteria used, anywhere from 58% to 100% of patients were judged to have experienced a withdrawal reaction, with a peak severity at 2 days for short half-life and 4 to 7 days for long half-life benzodiazepines. Relapse onto benzodiazepines occurred in 27% of patients who were receiving long half-life benzodiazepines and in 57% of patients who were receiving short half-life benzodiazepines. Baseline predictors of relapse were nonpanic diagnoses, a higher benzodiazepine dose, and a higher Eysenck neuroticism score. A short half-life and higher daily doses were associated with greater withdrawal severity, as were personality traits, such as dependency and neuroticism, less education and higher baseline levels of anxious and depressive symptoms. Patients who were able to remain free of benzodiazepines for at least 5 weeks obtained lower levels of anxiety than before benzodiazepine discontinuation. These results provide a detailed picture of the symptoms, time course, and multidimensional determinants of the benzodiazepine withdrawal syndrome.

Overview

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1990.01810220015002

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 35 references

Cited by

See all 333

Metadata

Authors
Rickels, K.
Affiliations
University of Pennsylvania (US)
Corresponding author
Rickels, Karl
Venue
Archives of General Psychiatry
Published
1990-10-01
Volume
47
Issue
10
Pages
899
ISSN
0003-990X (ISSN-L)
OpenAlex
W1998935547
Cited by
332
References
35
Citations by year
2026: 9 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 15 · 2021: 6 · 2020: 9 · 2019: 9 · 2018: 16 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 10
FWCI
15.70
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of General Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (MH-08957, MH 34223)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
benzodiazepine withdrawal syndrome, benzodiazepine dependence, benzodiazepine discontinuation, relapse, withdrawal severity, predictors of relapse, neuroticism, anxiety, depression
MeSH terms
Ambulatory Care, Anxiety Disorders, Benzodiazepines, Dependent Personality Disorder, Depressive Disorder, Diazepam, Double-Blind Method, Factor Analysis, Statistical, Half-Life, Humans, Outcome and Process Assessment, Health Care, Panic, Personality Inventory, Placebos, Psychiatric Status Rating Scales, Substance Withdrawal Syndrome, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation. https://app.cochat.ai/papers/10.1001/archpsyc.1990.01810220015002
The paper
Rickels, K. (1990). Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1990.01810220015002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.